NEPA Plus Dexamethasone Provide Superior Chemotherapy-Induced Nausea and Vomiting Prevention Compared with SoC Antiemetic Prophylaxis By Ogkologos - November 18, 2025 99 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from MyRisk study Source RELATED ARTICLESMORE FROM AUTHOR Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in Patients with TP53 Y220C-mutated Solid Tumours Rare Disease Day 2026: Advancing equity for people living with rare cancers in Europe EMA Recommends Extension of Therapeutic Indications for Ponatinib MOST POPULAR Study Links Non-Diet Soda Consumption with a Higher Risk of Death... March 16, 2021 Some Hormone Therapy Drugs For Breast Cancer Could Reduce Alzheimer’s Risk May 8, 2020 How CRISPR is Changing Cancer Research and Treatment July 27, 2020 Marginal Benefit in Overall and Progression-Free Survival from New Anticancer Drugs August 12, 2022 Load more HOT NEWS Adjuvant Abemaciclib Combined with Endocrine Therapy Improves IDFS in HR-Positive, HER2−Negative,... FDA Amends Approval of Pembrolizumab to Treat Stomach and Esophageal Junction... First New Drug in Years Reduces Recurrence in High-risk Hormone Receptor... What Comes after NCI-MATCH? NCI’s New Precision Medicine Cancer Trials
